118 related articles for article (PubMed ID: 7606879)
1. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
3. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
[TBL] [Abstract][Full Text] [Related]
4. Importance of iron supply for erythropoietin therapy.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170
[TBL] [Abstract][Full Text] [Related]
5. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
Saltissi D; Sauvage D; Westhuyzen J
Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
Fishbane S; Lynn RI
Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
[TBL] [Abstract][Full Text] [Related]
7. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients.
Hackeng CM; Beerenhout CM; Hermans M; Van der Kuy PH; Van der Dussen H; Van Dieijen-Visser MP; Hamulyák K; Van der Sande FM; Leunissen KM; Kooman JP
J Nephrol; 2004; 17(1):107-11. PubMed ID: 15151266
[TBL] [Abstract][Full Text] [Related]
8. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
Raja R; Bloom E; Johnson R; Goldstein M
Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
[TBL] [Abstract][Full Text] [Related]
9. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
[TBL] [Abstract][Full Text] [Related]
10. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
11. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
[TBL] [Abstract][Full Text] [Related]
13. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
Svára F; Sulková S; Kvasnićka J; Polakovic V
Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of iron requirements in renal patients on erythropoietin.
Anastassiades EG; Howarth D; Howarth J; Shanks D; Waters HM; Hyde K; Geary CG; Yin JA; Gokal R
Nephrol Dial Transplant; 1993; 8(9):846-53. PubMed ID: 8255518
[TBL] [Abstract][Full Text] [Related]
15. [Role of iron deficiency in erythropoietin sensitivity in dialysis patients with elevated C-reactive protein].
Martone M; Zanchi R; Panzetta G
G Ital Nefrol; 2003; 20(1):31-7. PubMed ID: 12647284
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin and tissue iron in anemic dialysis patients.
Bárány P; Eriksson LC; Hultcrantz R; Pettersson E; Bergström J
Miner Electrolyte Metab; 1997; 23(3-6):273-6. PubMed ID: 9387132
[TBL] [Abstract][Full Text] [Related]
17. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
[TBL] [Abstract][Full Text] [Related]
18. The plasma ferritin level as a reliable index of body iron stores following intravenous iron dextran.
Jacobs P; Dommisse J
J Med; 1982; 13(4):309-21. PubMed ID: 6957530
[TBL] [Abstract][Full Text] [Related]
19. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
[TBL] [Abstract][Full Text] [Related]
20. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]